Clinical Trial Update: Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of a prostate-specific membrane antigen antibody-drug conjugate in men with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Prostate-specific membrane antigen antibody-drug conjugate

Snippet

Sponsor: Progenics Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED